Cas:10425-05-5 (5-tert-butyl-2-hydroxyphenyl)-phenylmethanone manufacturer & supplier

Chemical Name:(5-tert-butyl-2-hydroxyphenyl)-phenylmethanone

CAS.NO:10425-05-5

Synonyms:5-tert-Butyl-2-hydroxy-benzophenon;[5-(1,1-dimethylethyl)-2-hydroxyphenyl]phenyl-methanone;5-(tert-butyl)-2-hydroxyphenyl phenyl ketone;5-tert-butyl-2-hydroxybenzophenone;2-benzoyl-4-tert-butylphenol;[5-(tert-butyl)-2-hydroxyphenyl](phenyl)methanone

Molecular Formula:C₁₇H₁₈O₂

Molecular Weight:254.32400

HS Code:2914501900

Physical and Chemical Properties:

Melting point:N/A

Boiling point:370.5ºC at 760mmHg

Density:1.093g/cm3

Index of Refraction:1.569

PSA:37.30000

Exact Mass:254.13100

LogP:3.92070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-tert-Butyl-2-hydroxy-benzophenon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[5-(tert-butyl)-2-hydroxyphenyl](phenyl)methanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(tert-butyl)-2-hydroxyphenyl phenyl ketone Use and application,5-(tert-butyl)-2-hydroxyphenyl phenyl ketone technical grade,usp/ep/jp grade.

Related News: Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. (5-tert-butyl-2-hydroxyphenyl)-phenylmethanone manufacturer Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. (5-tert-butyl-2-hydroxyphenyl)-phenylmethanone supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. (5-tert-butyl-2-hydroxyphenyl)-phenylmethanone vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. (5-tert-butyl-2-hydroxyphenyl)-phenylmethanone factory The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA.